Evonik stock heads into the open after a 2.9 percent drop
Published on 09/17/2026 at 06:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evonik stock closed at 17.44 EUR on Xetra on September 15, 2026, losing 2.9 percent compared with the prior session according to market data. Per the same Xetra quote, the shares traded between 17.32 EUR and 17.80 EUR during the day, with turnover noticeably above the recent average. As Aktiencheck reported on September 16, 2026, an analyst downgrade highlighting increasing risks in the animal nutrition business weighed on sentiment.
September 15, 2026 in numbers
Evonik Industries AG (ISIN DE000EVNK013) saw its Xetra quotation finish at 17.44 EUR on September 15, 2026, which marked a 2.9 percent decline for the day versus the previous close, based on Xetra market statistics. The intraday range between approximately 17.32 EUR and 17.80 EUR showed that the share spent most of the session below the 18 EUR level. Trading volume on Xetra for Evonik on September 15, 2026 was significantly higher than on the prior day, indicating that the downgrade was met with active repositioning by investors.
Compared with the MDAX performance on September 15, 2026, Evonik lagged its mid-cap peers, as the index moved only modestly lower while Evonik dropped 2.9 percent, according to German market overviews. As Ad-hoc-news noted on September 16, 2026, the analyst move left only a small upside to the new price target, reinforcing the cautious tone around the share.
Outlook today, September 17, 2026
Today, September 17, 2026, investors focus on whether Evonik will comment further on its animal nutrition strategy in upcoming presentations and conference appearances listed in the investor relations calendar. According to the company financial calendar cited by Finanzen.ch, Evonik has scheduled its next quarterly reporting within the coming weeks, so preparatory remarks or guidance hints may attract attention ahead of that date. Broader market sentiment is also shaped by the recent decline in leading global equity indices following concerns over growth and interest rates, which can influence cyclical industrials such as Evonik.
